nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—GRIN2A—melanoma	0.703	1	CbGaD
Memantine—Malnutrition—Carmustine—melanoma	0.000201	0.00106	CcSEcCtD
Memantine—Cough—Bleomycin—melanoma	0.000201	0.00106	CcSEcCtD
Memantine—Chills—Temozolomide—melanoma	0.000201	0.00105	CcSEcCtD
Memantine—Dehydration—Docetaxel—melanoma	0.0002	0.00105	CcSEcCtD
Memantine—Ill-defined disorder—Dactinomycin—melanoma	0.0002	0.00105	CcSEcCtD
Memantine—Anaemia—Dactinomycin—melanoma	0.000199	0.00104	CcSEcCtD
Memantine—Liver function test abnormal—Docetaxel—melanoma	0.000198	0.00104	CcSEcCtD
Memantine—Vomiting—Vemurafenib—melanoma	0.000198	0.00104	CcSEcCtD
Memantine—Alopecia—Temozolomide—melanoma	0.000197	0.00104	CcSEcCtD
Memantine—Dry skin—Docetaxel—melanoma	0.000197	0.00103	CcSEcCtD
Memantine—Chest pain—Bleomycin—melanoma	0.000196	0.00103	CcSEcCtD
Memantine—Myalgia—Bleomycin—melanoma	0.000196	0.00103	CcSEcCtD
Memantine—Orthostatic hypotension—Docetaxel—melanoma	0.000196	0.00103	CcSEcCtD
Memantine—Rash—Vemurafenib—melanoma	0.000196	0.00103	CcSEcCtD
Memantine—Mental disorder—Temozolomide—melanoma	0.000196	0.00103	CcSEcCtD
Memantine—Dermatitis—Vemurafenib—melanoma	0.000196	0.00103	CcSEcCtD
Memantine—Back pain—Carmustine—melanoma	0.000195	0.00102	CcSEcCtD
Memantine—Headache—Vemurafenib—melanoma	0.000195	0.00102	CcSEcCtD
Memantine—Malnutrition—Temozolomide—melanoma	0.000195	0.00102	CcSEcCtD
Memantine—Discomfort—Bleomycin—melanoma	0.000194	0.00102	CcSEcCtD
Memantine—Malaise—Dactinomycin—melanoma	0.000194	0.00102	CcSEcCtD
Memantine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000193	0.00102	CcSEcCtD
Memantine—Leukopenia—Dactinomycin—melanoma	0.000193	0.00101	CcSEcCtD
Memantine—Nasopharyngitis—Docetaxel—melanoma	0.000192	0.00101	CcSEcCtD
Memantine—Dysgeusia—Temozolomide—melanoma	0.00019	0.001	CcSEcCtD
Memantine—Confusional state—Bleomycin—melanoma	0.00019	0.000997	CcSEcCtD
Memantine—Vision blurred—Carmustine—melanoma	0.00019	0.000997	CcSEcCtD
Memantine—Alanine aminotransferase increased—Docetaxel—melanoma	0.000189	0.000995	CcSEcCtD
Memantine—Tremor—Carmustine—melanoma	0.000189	0.000991	CcSEcCtD
Memantine—Oedema—Bleomycin—melanoma	0.000188	0.000989	CcSEcCtD
Memantine—Back pain—Temozolomide—melanoma	0.000188	0.000989	CcSEcCtD
Memantine—Infection—Bleomycin—melanoma	0.000187	0.000982	CcSEcCtD
Memantine—Anaemia—Carmustine—melanoma	0.000186	0.000977	CcSEcCtD
Memantine—Dysphagia—Docetaxel—melanoma	0.000186	0.000975	CcSEcCtD
Memantine—Agitation—Carmustine—melanoma	0.000185	0.000972	CcSEcCtD
Memantine—Nausea—Vemurafenib—melanoma	0.000185	0.000969	CcSEcCtD
Memantine—Thrombocytopenia—Bleomycin—melanoma	0.000184	0.000968	CcSEcCtD
Memantine—Vision blurred—Temozolomide—melanoma	0.000183	0.000963	CcSEcCtD
Memantine—Myalgia—Dactinomycin—melanoma	0.000183	0.000962	CcSEcCtD
Memantine—Bronchospasm—Docetaxel—melanoma	0.000183	0.000959	CcSEcCtD
Memantine—Tremor—Temozolomide—melanoma	0.000182	0.000957	CcSEcCtD
Memantine—Discomfort—Dactinomycin—melanoma	0.000181	0.00095	CcSEcCtD
Memantine—Angina pectoris—Docetaxel—melanoma	0.000181	0.00095	CcSEcCtD
Memantine—Ill-defined disorder—Temozolomide—melanoma	0.00018	0.000948	CcSEcCtD
Memantine—Leukopenia—Carmustine—melanoma	0.00018	0.000947	CcSEcCtD
Memantine—Anaemia—Temozolomide—melanoma	0.00018	0.000945	CcSEcCtD
Memantine—Anorexia—Bleomycin—melanoma	0.000179	0.000943	CcSEcCtD
Memantine—Agitation—Temozolomide—melanoma	0.000179	0.000939	CcSEcCtD
Memantine—Pancytopenia—Docetaxel—melanoma	0.000176	0.000926	CcSEcCtD
Memantine—Hypotension—Bleomycin—melanoma	0.000176	0.000924	CcSEcCtD
Memantine—Oedema—Dactinomycin—melanoma	0.000176	0.000922	CcSEcCtD
Memantine—Malaise—Temozolomide—melanoma	0.000175	0.000922	CcSEcCtD
Memantine—Vertigo—Temozolomide—melanoma	0.000175	0.000918	CcSEcCtD
Memantine—Convulsion—Carmustine—melanoma	0.000174	0.000916	CcSEcCtD
Memantine—Infection—Dactinomycin—melanoma	0.000174	0.000916	CcSEcCtD
Memantine—Leukopenia—Temozolomide—melanoma	0.000174	0.000915	CcSEcCtD
Memantine—Hypertension—Carmustine—melanoma	0.000174	0.000913	CcSEcCtD
Memantine—Neutropenia—Docetaxel—melanoma	0.000174	0.000912	CcSEcCtD
Memantine—Palpitations—Temozolomide—melanoma	0.000172	0.000903	CcSEcCtD
Memantine—Thrombocytopenia—Dactinomycin—melanoma	0.000172	0.000903	CcSEcCtD
Memantine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000171	0.000901	CcSEcCtD
Memantine—Chest pain—Carmustine—melanoma	0.000171	0.0009	CcSEcCtD
Memantine—Myalgia—Carmustine—melanoma	0.000171	0.0009	CcSEcCtD
Memantine—Anxiety—Carmustine—melanoma	0.000171	0.000897	CcSEcCtD
Memantine—Cough—Temozolomide—melanoma	0.00017	0.000892	CcSEcCtD
Memantine—Paraesthesia—Bleomycin—melanoma	0.000169	0.000888	CcSEcCtD
Memantine—Weight increased—Docetaxel—melanoma	0.000169	0.000888	CcSEcCtD
Memantine—Convulsion—Temozolomide—melanoma	0.000169	0.000885	CcSEcCtD
Memantine—Weight decreased—Docetaxel—melanoma	0.000168	0.000882	CcSEcCtD
Memantine—Hypertension—Temozolomide—melanoma	0.000168	0.000882	CcSEcCtD
Memantine—Dyspnoea—Bleomycin—melanoma	0.000168	0.000882	CcSEcCtD
Memantine—Anorexia—Dactinomycin—melanoma	0.000167	0.000879	CcSEcCtD
Memantine—Pneumonia—Docetaxel—melanoma	0.000167	0.000875	CcSEcCtD
Memantine—Confusional state—Carmustine—melanoma	0.000166	0.00087	CcSEcCtD
Memantine—Myalgia—Temozolomide—melanoma	0.000166	0.00087	CcSEcCtD
Memantine—Arthralgia—Temozolomide—melanoma	0.000166	0.00087	CcSEcCtD
Memantine—Infestation NOS—Docetaxel—melanoma	0.000166	0.00087	CcSEcCtD
Memantine—Infestation—Docetaxel—melanoma	0.000166	0.00087	CcSEcCtD
Memantine—Anxiety—Temozolomide—melanoma	0.000165	0.000867	CcSEcCtD
Memantine—Oedema—Carmustine—melanoma	0.000164	0.000863	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000164	0.000862	CcSEcCtD
Memantine—Discomfort—Temozolomide—melanoma	0.000164	0.00086	CcSEcCtD
Memantine—Decreased appetite—Bleomycin—melanoma	0.000164	0.00086	CcSEcCtD
Memantine—Infection—Carmustine—melanoma	0.000163	0.000857	CcSEcCtD
Memantine—Acute coronary syndrome—Docetaxel—melanoma	0.000163	0.000857	CcSEcCtD
Memantine—Renal failure—Docetaxel—melanoma	0.000163	0.000855	CcSEcCtD
Memantine—Neuropathy peripheral—Docetaxel—melanoma	0.000162	0.000852	CcSEcCtD
Memantine—Myocardial infarction—Docetaxel—melanoma	0.000162	0.000852	CcSEcCtD
Memantine—Dry mouth—Temozolomide—melanoma	0.000162	0.000851	CcSEcCtD
Memantine—Pain—Bleomycin—melanoma	0.000161	0.000846	CcSEcCtD
Memantine—Conjunctivitis—Docetaxel—melanoma	0.000161	0.000845	CcSEcCtD
Memantine—Thrombocytopenia—Carmustine—melanoma	0.000161	0.000845	CcSEcCtD
Memantine—Tachycardia—Carmustine—melanoma	0.00016	0.000842	CcSEcCtD
Memantine—Confusional state—Temozolomide—melanoma	0.00016	0.000841	CcSEcCtD
Memantine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00016	0.00084	CcSEcCtD
Memantine—Oedema—Temozolomide—melanoma	0.000159	0.000834	CcSEcCtD
Memantine—Infection—Temozolomide—melanoma	0.000158	0.000829	CcSEcCtD
Memantine—Anorexia—Carmustine—melanoma	0.000157	0.000823	CcSEcCtD
Memantine—Hepatobiliary disease—Docetaxel—melanoma	0.000157	0.000823	CcSEcCtD
Memantine—Epistaxis—Docetaxel—melanoma	0.000156	0.00082	CcSEcCtD
Memantine—Nervous system disorder—Temozolomide—melanoma	0.000156	0.000818	CcSEcCtD
Memantine—Thrombocytopenia—Temozolomide—melanoma	0.000155	0.000817	CcSEcCtD
Memantine—Feeling abnormal—Bleomycin—melanoma	0.000155	0.000815	CcSEcCtD
Memantine—Agranulocytosis—Docetaxel—melanoma	0.000154	0.000812	CcSEcCtD
Memantine—Skin disorder—Temozolomide—melanoma	0.000154	0.00081	CcSEcCtD
Memantine—Hypotension—Carmustine—melanoma	0.000154	0.000807	CcSEcCtD
Memantine—Hyperhidrosis—Temozolomide—melanoma	0.000153	0.000806	CcSEcCtD
Memantine—Decreased appetite—Dactinomycin—melanoma	0.000153	0.000802	CcSEcCtD
Memantine—Fatigue—Dactinomycin—melanoma	0.000151	0.000795	CcSEcCtD
Memantine—Anorexia—Temozolomide—melanoma	0.000151	0.000795	CcSEcCtD
Memantine—Pain—Dactinomycin—melanoma	0.00015	0.000789	CcSEcCtD
Memantine—Musculoskeletal discomfort—Carmustine—melanoma	0.00015	0.000786	CcSEcCtD
Memantine—Urticaria—Bleomycin—melanoma	0.00015	0.000786	CcSEcCtD
Memantine—Haemoglobin—Docetaxel—melanoma	0.000149	0.000785	CcSEcCtD
Memantine—Rhinitis—Docetaxel—melanoma	0.000149	0.000783	CcSEcCtD
Memantine—Body temperature increased—Bleomycin—melanoma	0.000149	0.000782	CcSEcCtD
Memantine—Haemorrhage—Docetaxel—melanoma	0.000149	0.000781	CcSEcCtD
Memantine—Hepatitis—Docetaxel—melanoma	0.000149	0.000781	CcSEcCtD
Memantine—Insomnia—Carmustine—melanoma	0.000149	0.000781	CcSEcCtD
Memantine—Hypoaesthesia—Docetaxel—melanoma	0.000148	0.000777	CcSEcCtD
Memantine—Paraesthesia—Carmustine—melanoma	0.000148	0.000775	CcSEcCtD
Memantine—Pharyngitis—Docetaxel—melanoma	0.000147	0.000775	CcSEcCtD
Memantine—Urinary tract disorder—Docetaxel—melanoma	0.000147	0.000771	CcSEcCtD
Memantine—Dyspnoea—Carmustine—melanoma	0.000146	0.000769	CcSEcCtD
Memantine—Oedema peripheral—Docetaxel—melanoma	0.000146	0.000769	CcSEcCtD
Memantine—Somnolence—Carmustine—melanoma	0.000146	0.000767	CcSEcCtD
Memantine—Connective tissue disorder—Docetaxel—melanoma	0.000146	0.000767	CcSEcCtD
Memantine—Urethral disorder—Docetaxel—melanoma	0.000146	0.000765	CcSEcCtD
Memantine—Feeling abnormal—Dactinomycin—melanoma	0.000145	0.00076	CcSEcCtD
Memantine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000145	0.00076	CcSEcCtD
Memantine—Insomnia—Temozolomide—melanoma	0.000144	0.000754	CcSEcCtD
Memantine—Gastrointestinal pain—Dactinomycin—melanoma	0.000144	0.000754	CcSEcCtD
Memantine—Visual impairment—Docetaxel—melanoma	0.000143	0.000752	CcSEcCtD
Memantine—Decreased appetite—Carmustine—melanoma	0.000143	0.00075	CcSEcCtD
Memantine—Paraesthesia—Temozolomide—melanoma	0.000143	0.000749	CcSEcCtD
Memantine—Gastrointestinal disorder—Carmustine—melanoma	0.000142	0.000745	CcSEcCtD
Memantine—Dyspnoea—Temozolomide—melanoma	0.000142	0.000744	CcSEcCtD
Memantine—Somnolence—Temozolomide—melanoma	0.000141	0.000741	CcSEcCtD
Memantine—Erythema multiforme—Docetaxel—melanoma	0.000141	0.000738	CcSEcCtD
Memantine—Pain—Carmustine—melanoma	0.00014	0.000738	CcSEcCtD
Memantine—Constipation—Carmustine—melanoma	0.00014	0.000738	CcSEcCtD
Memantine—Dyspepsia—Temozolomide—melanoma	0.00014	0.000734	CcSEcCtD
Memantine—Eye disorder—Docetaxel—melanoma	0.000139	0.00073	CcSEcCtD
Memantine—Abdominal pain—Dactinomycin—melanoma	0.000139	0.000729	CcSEcCtD
Memantine—Body temperature increased—Dactinomycin—melanoma	0.000139	0.000729	CcSEcCtD
Memantine—Hypersensitivity—Bleomycin—melanoma	0.000139	0.000728	CcSEcCtD
Memantine—Decreased appetite—Temozolomide—melanoma	0.000138	0.000725	CcSEcCtD
Memantine—Flushing—Docetaxel—melanoma	0.000138	0.000725	CcSEcCtD
Memantine—Cardiac disorder—Docetaxel—melanoma	0.000138	0.000725	CcSEcCtD
Memantine—Gastrointestinal disorder—Temozolomide—melanoma	0.000137	0.00072	CcSEcCtD
Memantine—Fatigue—Temozolomide—melanoma	0.000137	0.000719	CcSEcCtD
Memantine—Constipation—Temozolomide—melanoma	0.000136	0.000713	CcSEcCtD
Memantine—Pain—Temozolomide—melanoma	0.000136	0.000713	CcSEcCtD
Memantine—Feeling abnormal—Carmustine—melanoma	0.000135	0.000711	CcSEcCtD
Memantine—Asthenia—Bleomycin—melanoma	0.000135	0.000709	CcSEcCtD
Memantine—Angiopathy—Docetaxel—melanoma	0.000135	0.000708	CcSEcCtD
Memantine—Gastrointestinal pain—Carmustine—melanoma	0.000134	0.000706	CcSEcCtD
Memantine—Immune system disorder—Docetaxel—melanoma	0.000134	0.000705	CcSEcCtD
Memantine—Mediastinal disorder—Docetaxel—melanoma	0.000134	0.000704	CcSEcCtD
Memantine—Chills—Docetaxel—melanoma	0.000133	0.000701	CcSEcCtD
Memantine—Pruritus—Bleomycin—melanoma	0.000133	0.0007	CcSEcCtD
Memantine—Arrhythmia—Docetaxel—melanoma	0.000133	0.000697	CcSEcCtD
Memantine—Alopecia—Docetaxel—melanoma	0.000131	0.00069	CcSEcCtD
Memantine—Feeling abnormal—Temozolomide—melanoma	0.000131	0.000687	CcSEcCtD
Memantine—Mental disorder—Docetaxel—melanoma	0.00013	0.000684	CcSEcCtD
Memantine—Body temperature increased—Carmustine—melanoma	0.00013	0.000682	CcSEcCtD
Memantine—Abdominal pain—Carmustine—melanoma	0.00013	0.000682	CcSEcCtD
Memantine—Gastrointestinal pain—Temozolomide—melanoma	0.00013	0.000682	CcSEcCtD
Memantine—Malnutrition—Docetaxel—melanoma	0.000129	0.00068	CcSEcCtD
Memantine—Hypersensitivity—Dactinomycin—melanoma	0.000129	0.000679	CcSEcCtD
Memantine—Dysgeusia—Docetaxel—melanoma	0.000127	0.000666	CcSEcCtD
Memantine—Urticaria—Temozolomide—melanoma	0.000126	0.000663	CcSEcCtD
Memantine—Asthenia—Dactinomycin—melanoma	0.000126	0.000662	CcSEcCtD
Memantine—Abdominal pain—Temozolomide—melanoma	0.000126	0.000659	CcSEcCtD
Memantine—Body temperature increased—Temozolomide—melanoma	0.000126	0.000659	CcSEcCtD
Memantine—Back pain—Docetaxel—melanoma	0.000125	0.000657	CcSEcCtD
Memantine—Hypersensitivity—Carmustine—melanoma	0.000121	0.000636	CcSEcCtD
Memantine—Diarrhoea—Dactinomycin—melanoma	0.00012	0.000631	CcSEcCtD
Memantine—Vomiting—Bleomycin—melanoma	0.00012	0.000629	CcSEcCtD
Memantine—Anaemia—Docetaxel—melanoma	0.00012	0.000628	CcSEcCtD
Memantine—Rash—Bleomycin—melanoma	0.000119	0.000623	CcSEcCtD
Memantine—Dermatitis—Bleomycin—melanoma	0.000119	0.000623	CcSEcCtD
Memantine—Asthenia—Carmustine—melanoma	0.000118	0.000619	CcSEcCtD
Memantine—Hypersensitivity—Temozolomide—melanoma	0.000117	0.000615	CcSEcCtD
Memantine—Syncope—Docetaxel—melanoma	0.000116	0.000609	CcSEcCtD
Memantine—Leukopenia—Docetaxel—melanoma	0.000116	0.000608	CcSEcCtD
Memantine—Palpitations—Docetaxel—melanoma	0.000114	0.000601	CcSEcCtD
Memantine—Asthenia—Temozolomide—melanoma	0.000114	0.000598	CcSEcCtD
Memantine—Loss of consciousness—Docetaxel—melanoma	0.000114	0.000597	CcSEcCtD
Memantine—Cough—Docetaxel—melanoma	0.000113	0.000593	CcSEcCtD
Memantine—Diarrhoea—Carmustine—melanoma	0.000112	0.000591	CcSEcCtD
Memantine—Pruritus—Temozolomide—melanoma	0.000112	0.00059	CcSEcCtD
Memantine—Convulsion—Docetaxel—melanoma	0.000112	0.000589	CcSEcCtD
Memantine—Nausea—Bleomycin—melanoma	0.000112	0.000587	CcSEcCtD
Memantine—Hypertension—Docetaxel—melanoma	0.000112	0.000587	CcSEcCtD
Memantine—Vomiting—Dactinomycin—melanoma	0.000112	0.000586	CcSEcCtD
Memantine—Rash—Dactinomycin—melanoma	0.000111	0.000581	CcSEcCtD
Memantine—Arthralgia—Docetaxel—melanoma	0.00011	0.000579	CcSEcCtD
Memantine—Chest pain—Docetaxel—melanoma	0.00011	0.000579	CcSEcCtD
Memantine—Myalgia—Docetaxel—melanoma	0.00011	0.000579	CcSEcCtD
Memantine—Dizziness—Carmustine—melanoma	0.000109	0.000571	CcSEcCtD
Memantine—Diarrhoea—Temozolomide—melanoma	0.000109	0.000571	CcSEcCtD
Memantine—Dry mouth—Docetaxel—melanoma	0.000108	0.000566	CcSEcCtD
Memantine—Confusional state—Docetaxel—melanoma	0.000106	0.000559	CcSEcCtD
Memantine—Oedema—Docetaxel—melanoma	0.000106	0.000555	CcSEcCtD
Memantine—Dizziness—Temozolomide—melanoma	0.000105	0.000552	CcSEcCtD
Memantine—Infection—Docetaxel—melanoma	0.000105	0.000551	CcSEcCtD
Memantine—Vomiting—Carmustine—melanoma	0.000104	0.000549	CcSEcCtD
Memantine—Nausea—Dactinomycin—melanoma	0.000104	0.000548	CcSEcCtD
Memantine—Shock—Docetaxel—melanoma	0.000104	0.000546	CcSEcCtD
Memantine—Rash—Carmustine—melanoma	0.000104	0.000544	CcSEcCtD
Memantine—Nervous system disorder—Docetaxel—melanoma	0.000104	0.000544	CcSEcCtD
Memantine—Dermatitis—Carmustine—melanoma	0.000103	0.000544	CcSEcCtD
Memantine—Thrombocytopenia—Docetaxel—melanoma	0.000103	0.000543	CcSEcCtD
Memantine—Tachycardia—Docetaxel—melanoma	0.000103	0.000541	CcSEcCtD
Memantine—Headache—Carmustine—melanoma	0.000103	0.000541	CcSEcCtD
Memantine—Skin disorder—Docetaxel—melanoma	0.000103	0.000539	CcSEcCtD
Memantine—Vomiting—Temozolomide—melanoma	0.000101	0.00053	CcSEcCtD
Memantine—Anorexia—Docetaxel—melanoma	0.000101	0.000529	CcSEcCtD
Memantine—Rash—Temozolomide—melanoma	0.0001	0.000526	CcSEcCtD
Memantine—Dermatitis—Temozolomide—melanoma	0.0001	0.000525	CcSEcCtD
Memantine—Headache—Temozolomide—melanoma	9.95e-05	0.000523	CcSEcCtD
Memantine—Hypotension—Docetaxel—melanoma	9.87e-05	0.000518	CcSEcCtD
Memantine—Nausea—Carmustine—melanoma	9.76e-05	0.000513	CcSEcCtD
Memantine—Musculoskeletal discomfort—Docetaxel—melanoma	9.62e-05	0.000505	CcSEcCtD
Memantine—Insomnia—Docetaxel—melanoma	9.55e-05	0.000502	CcSEcCtD
Memantine—Paraesthesia—Docetaxel—melanoma	9.48e-05	0.000498	CcSEcCtD
Memantine—Nausea—Temozolomide—melanoma	9.43e-05	0.000495	CcSEcCtD
Memantine—Dyspnoea—Docetaxel—melanoma	9.41e-05	0.000495	CcSEcCtD
Memantine—Somnolence—Docetaxel—melanoma	9.39e-05	0.000493	CcSEcCtD
Memantine—Dyspepsia—Docetaxel—melanoma	9.29e-05	0.000488	CcSEcCtD
Memantine—Decreased appetite—Docetaxel—melanoma	9.18e-05	0.000482	CcSEcCtD
Memantine—Gastrointestinal disorder—Docetaxel—melanoma	9.11e-05	0.000479	CcSEcCtD
Memantine—Fatigue—Docetaxel—melanoma	9.1e-05	0.000478	CcSEcCtD
Memantine—Constipation—Docetaxel—melanoma	9.03e-05	0.000474	CcSEcCtD
Memantine—Pain—Docetaxel—melanoma	9.03e-05	0.000474	CcSEcCtD
Memantine—Feeling abnormal—Docetaxel—melanoma	8.7e-05	0.000457	CcSEcCtD
Memantine—Gastrointestinal pain—Docetaxel—melanoma	8.63e-05	0.000454	CcSEcCtD
Memantine—Abdominal pain—Docetaxel—melanoma	8.35e-05	0.000438	CcSEcCtD
Memantine—Body temperature increased—Docetaxel—melanoma	8.35e-05	0.000438	CcSEcCtD
Memantine—Hypersensitivity—Docetaxel—melanoma	7.78e-05	0.000409	CcSEcCtD
Memantine—Asthenia—Docetaxel—melanoma	7.57e-05	0.000398	CcSEcCtD
Memantine—Pruritus—Docetaxel—melanoma	7.47e-05	0.000392	CcSEcCtD
Memantine—Diarrhoea—Docetaxel—melanoma	7.22e-05	0.00038	CcSEcCtD
Memantine—Dizziness—Docetaxel—melanoma	6.98e-05	0.000367	CcSEcCtD
Memantine—Vomiting—Docetaxel—melanoma	6.71e-05	0.000353	CcSEcCtD
Memantine—Rash—Docetaxel—melanoma	6.66e-05	0.00035	CcSEcCtD
Memantine—Dermatitis—Docetaxel—melanoma	6.65e-05	0.000349	CcSEcCtD
Memantine—Headache—Docetaxel—melanoma	6.61e-05	0.000347	CcSEcCtD
Memantine—Nausea—Docetaxel—melanoma	6.27e-05	0.000329	CcSEcCtD
Memantine—CYP2B6—Metabolism—CUBN—melanoma	1.93e-05	0.000182	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—KRAS—melanoma	1.93e-05	0.000182	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCR4—melanoma	1.92e-05	0.00018	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PLA2G6—melanoma	1.9e-05	0.000179	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—GNAQ—melanoma	1.9e-05	0.000178	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TNF—melanoma	1.9e-05	0.000178	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—KRAS—melanoma	1.88e-05	0.000177	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SDHD—melanoma	1.87e-05	0.000175	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—BSG—melanoma	1.87e-05	0.000175	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CSPG4—melanoma	1.87e-05	0.000175	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—VCAN—melanoma	1.86e-05	0.000175	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PLCB4—melanoma	1.86e-05	0.000175	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KISS1—melanoma	1.86e-05	0.000175	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GAB2—melanoma	1.85e-05	0.000174	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GNA11—melanoma	1.85e-05	0.000174	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	1.85e-05	0.000174	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	1.83e-05	0.000172	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GPAM—melanoma	1.81e-05	0.00017	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SKI—melanoma	1.8e-05	0.000169	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCR1—melanoma	1.8e-05	0.000169	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MC1R—melanoma	1.77e-05	0.000167	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—HRAS—melanoma	1.76e-05	0.000165	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT3—melanoma	1.75e-05	0.000165	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIP4K2A—melanoma	1.75e-05	0.000164	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC6A11—melanoma	1.75e-05	0.000164	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCR4—melanoma	1.74e-05	0.000164	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GNAQ—melanoma	1.72e-05	0.000162	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—VCAN—melanoma	1.71e-05	0.000161	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MTAP—melanoma	1.7e-05	0.00016	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GRM1—melanoma	1.7e-05	0.00016	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR7—melanoma	1.7e-05	0.00016	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—MAPK1—melanoma	1.68e-05	0.000158	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.66e-05	0.000156	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SUFU—melanoma	1.66e-05	0.000156	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—HRAS—melanoma	1.64e-05	0.000154	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—melanoma	1.62e-05	0.000152	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—HRAS—melanoma	1.6e-05	0.00015	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT3—melanoma	1.59e-05	0.00015	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP17A1—melanoma	1.57e-05	0.000148	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—IL6—melanoma	1.57e-05	0.000148	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RHOB—melanoma	1.55e-05	0.000145	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BCL2L11—melanoma	1.55e-05	0.000145	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PLA2G6—melanoma	1.54e-05	0.000144	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—IL6—melanoma	1.53e-05	0.000144	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PHGDH—melanoma	1.52e-05	0.000143	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—LUM—melanoma	1.52e-05	0.000143	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HPSE—melanoma	1.49e-05	0.00014	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HDAC6—melanoma	1.49e-05	0.00014	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GNA11—melanoma	1.48e-05	0.00014	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—IL6—melanoma	1.48e-05	0.000139	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—EDN1—melanoma	1.47e-05	0.000138	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CUBN—melanoma	1.46e-05	0.000137	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ALB—melanoma	1.45e-05	0.000137	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—FASN—melanoma	1.45e-05	0.000137	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—AKT1—melanoma	1.45e-05	0.000136	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP17A1—melanoma	1.44e-05	0.000136	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CSF2—melanoma	1.44e-05	0.000135	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC5A5—melanoma	1.43e-05	0.000134	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—AKT1—melanoma	1.41e-05	0.000133	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SDHD—melanoma	1.41e-05	0.000133	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—BSG—melanoma	1.41e-05	0.000133	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CSPG4—melanoma	1.41e-05	0.000133	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCR2—melanoma	1.41e-05	0.000132	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCL8—melanoma	1.41e-05	0.000132	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RAC2—melanoma	1.39e-05	0.00013	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GNAQ—melanoma	1.38e-05	0.00013	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CD44—melanoma	1.38e-05	0.00013	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—VCAN—melanoma	1.38e-05	0.00013	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PRKCA—melanoma	1.38e-05	0.00013	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GPAM—melanoma	1.37e-05	0.000128	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFC—melanoma	1.36e-05	0.000128	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—WNT5A—melanoma	1.36e-05	0.000128	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GNA11—melanoma	1.36e-05	0.000128	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—HRAS—melanoma	1.35e-05	0.000127	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EDN1—melanoma	1.34e-05	0.000126	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—FASN—melanoma	1.33e-05	0.000125	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP1B1—melanoma	1.32e-05	0.000124	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC5A5—melanoma	1.31e-05	0.000123	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CSF2—melanoma	1.31e-05	0.000123	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—RAC1—melanoma	1.28e-05	0.00012	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GNAQ—melanoma	1.27e-05	0.000119	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CD44—melanoma	1.27e-05	0.000119	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PRKCA—melanoma	1.25e-05	0.000118	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MAP2K2—melanoma	1.22e-05	0.000115	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP1B1—melanoma	1.21e-05	0.000114	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—F2R—melanoma	1.2e-05	0.000113	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP17A1—melanoma	1.16e-05	0.000109	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—RAC1—melanoma	1.16e-05	0.000109	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PLA2G6—melanoma	1.16e-05	0.000109	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EDNRB—melanoma	1.16e-05	0.000109	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTK2B—melanoma	1.13e-05	0.000106	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GNA11—melanoma	1.1e-05	0.000103	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GAB2—melanoma	1.1e-05	0.000103	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GNA11—melanoma	1.1e-05	0.000103	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FLT1—melanoma	1.09e-05	0.000103	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ABCB1—melanoma	1.09e-05	0.000102	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CG—melanoma	1.08e-05	0.000102	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—FASN—melanoma	1.08e-05	0.000101	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC5A5—melanoma	1.06e-05	9.95e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—VCAN—melanoma	1.04e-05	9.8e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCR4—melanoma	1.03e-05	9.68e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FOXO4—melanoma	1.03e-05	9.68e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HDAC2—melanoma	1.03e-05	9.68e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GNAQ—melanoma	1.02e-05	9.61e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CD44—melanoma	1.02e-05	9.61e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GNAQ—melanoma	1.02e-05	9.57e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PRKCA—melanoma	1e-05	9.42e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ABCB1—melanoma	1e-05	9.4e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ERCC2—melanoma	9.94e-06	9.35e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.87e-06	9.28e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CG—melanoma	9.81e-06	9.22e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP1B1—melanoma	9.8e-06	9.21e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SYK—melanoma	9.57e-06	9e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.52e-06	8.95e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CD—melanoma	9.5e-06	8.93e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT3—melanoma	9.4e-06	8.83e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NGFR—melanoma	9.4e-06	8.83e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ITGAV—melanoma	9.4e-06	8.83e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PRKCA—melanoma	9.2e-06	8.65e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ERCC2—melanoma	9.13e-06	8.58e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP17A1—melanoma	8.8e-06	8.27e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SOCS1—melanoma	8.7e-06	8.18e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MAP2K1—melanoma	8.68e-06	8.16e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—S100B—melanoma	8.68e-06	8.16e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.68e-06	8.16e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CD—melanoma	8.62e-06	8.11e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	8.56e-06	8.05e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GNA11—melanoma	8.31e-06	7.81e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ERBB4—melanoma	8.3e-06	7.8e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CB—melanoma	8.28e-06	7.78e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN2B—melanoma	8.23e-06	7.73e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—FASN—melanoma	8.13e-06	7.64e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCB1—melanoma	8.07e-06	7.59e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC5A5—melanoma	8e-06	7.52e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CD86—melanoma	7.96e-06	7.48e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL8—melanoma	7.95e-06	7.48e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EDN1—melanoma	7.89e-06	7.42e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CG—melanoma	7.85e-06	7.38e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GNAQ—melanoma	7.72e-06	7.26e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CD44—melanoma	7.72e-06	7.26e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CSF2—melanoma	7.72e-06	7.25e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FGF1—melanoma	7.72e-06	7.25e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IL2—melanoma	7.6e-06	7.15e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARG—melanoma	7.58e-06	7.12e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.56e-06	7.11e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—E2F1—melanoma	7.55e-06	7.1e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CB—melanoma	7.52e-06	7.07e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.49e-06	7.04e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PDGFRA—melanoma	7.47e-06	7.03e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PRKCA—melanoma	7.43e-06	6.98e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP1B1—melanoma	7.4e-06	6.96e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PRKCA—melanoma	7.4e-06	6.95e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ITGB3—melanoma	7.4e-06	6.95e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ERCC2—melanoma	7.36e-06	6.92e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SPP1—melanoma	7.25e-06	6.82e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAP2K2—melanoma	7.23e-06	6.8e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL8—melanoma	7.22e-06	6.79e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CG—melanoma	7.21e-06	6.78e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARG—melanoma	6.96e-06	6.54e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CD—melanoma	6.9e-06	6.49e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL2—melanoma	6.9e-06	6.49e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TERT—melanoma	6.88e-06	6.47e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RAC1—melanoma	6.86e-06	6.45e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALB—melanoma	6.81e-06	6.41e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HIF1A—melanoma	6.58e-06	6.18e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.53e-06	6.14e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CD—melanoma	6.34e-06	5.96e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KDR—melanoma	6.29e-06	5.91e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALB—melanoma	6.26e-06	5.88e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCB1—melanoma	6.1e-06	5.73e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FN1—melanoma	6.05e-06	5.69e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CB—melanoma	6.02e-06	5.66e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—melanoma	5.96e-06	5.6e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH1—melanoma	5.93e-06	5.57e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CG—melanoma	5.82e-06	5.47e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CD80—melanoma	5.81e-06	5.46e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CG—melanoma	5.79e-06	5.45e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APC—melanoma	5.79e-06	5.45e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KIT—melanoma	5.79e-06	5.45e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—NRAS—melanoma	5.79e-06	5.45e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGF—melanoma	5.73e-06	5.38e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARG—melanoma	5.61e-06	5.28e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PRKCA—melanoma	5.61e-06	5.27e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ERCC2—melanoma	5.56e-06	5.23e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MAPK3—melanoma	5.55e-06	5.22e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CB—melanoma	5.52e-06	5.19e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—melanoma	5.47e-06	5.15e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BRAF—melanoma	5.45e-06	5.12e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1—melanoma	5.31e-06	4.99e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MAPK1—melanoma	5.28e-06	4.96e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—melanoma	5.28e-06	4.96e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTEN—melanoma	5.2e-06	4.89e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAP2K1—melanoma	5.13e-06	4.82e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CD—melanoma	5.11e-06	4.81e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CD—melanoma	5.09e-06	4.79e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALB—melanoma	5.05e-06	4.74e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CA—melanoma	5.05e-06	4.74e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KRAS—melanoma	4.99e-06	4.69e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FGF2—melanoma	4.88e-06	4.59e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTEN—melanoma	4.77e-06	4.49e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.61e-06	4.33e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CA—melanoma	4.58e-06	4.31e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MDM2—melanoma	4.56e-06	4.29e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ERBB2—melanoma	4.5e-06	4.23e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CB—melanoma	4.46e-06	4.19e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CB—melanoma	4.44e-06	4.17e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—melanoma	4.42e-06	4.15e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CG—melanoma	4.39e-06	4.13e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL8—melanoma	4.27e-06	4.01e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARG—melanoma	4.24e-06	3.99e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HRAS—melanoma	4.24e-06	3.99e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN1B—melanoma	4.17e-06	3.92e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—melanoma	4.12e-06	3.87e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP3—melanoma	4.08e-06	3.84e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL2—melanoma	4.08e-06	3.83e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6—melanoma	4.06e-06	3.81e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCND1—melanoma	3.98e-06	3.74e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CTNNB1—melanoma	3.94e-06	3.7e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CD—melanoma	3.86e-06	3.63e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP9—melanoma	3.86e-06	3.63e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTEN—melanoma	3.85e-06	3.62e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN1A—melanoma	3.85e-06	3.62e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTEN—melanoma	3.84e-06	3.61e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NFKB1—melanoma	3.82e-06	3.59e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALB—melanoma	3.81e-06	3.59e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—melanoma	3.74e-06	3.52e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CA—melanoma	3.67e-06	3.45e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—melanoma	3.47e-06	3.26e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STAT3—melanoma	3.43e-06	3.23e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NRAS—melanoma	3.42e-06	3.22e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CB—melanoma	3.37e-06	3.17e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CA—melanoma	3.37e-06	3.17e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—melanoma	3.34e-06	3.14e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK3—melanoma	3.28e-06	3.08e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—melanoma	3.19e-06	3e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK1—melanoma	3.12e-06	2.93e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—melanoma	3.12e-06	2.93e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—melanoma	3e-06	2.82e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KRAS—melanoma	2.95e-06	2.77e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTEN—melanoma	2.91e-06	2.74e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—melanoma	2.75e-06	2.59e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CA—melanoma	2.72e-06	2.55e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CA—melanoma	2.71e-06	2.54e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—melanoma	2.62e-06	2.46e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HRAS—melanoma	2.5e-06	2.35e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6—melanoma	2.4e-06	2.25e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—melanoma	2.22e-06	2.09e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—melanoma	2.21e-06	2.08e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CA—melanoma	2.05e-06	1.93e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—melanoma	1.68e-06	1.58e-05	CbGpPWpGaD
